Question:
A multidisciplinary transplant team is evaluating a candidate for a vascularized composite allotransplantation (VCA) of the hand following traumatic amputation. During the planning meeting, there is discussion about the expected immunogenicity of the various tissue components in the graft and how this should guide the intensity of the postoperative immunosuppressive regimen. According to the established hierarchy of antigenicity in composite tissue transplants, which one of the following tissue components is considered the MOST antigenic and therefore the primary driver of the aggressive immune response requiring robust immunosuppression?
a) Cortical bone
b) Skeletal muscle
c) Articular cartilage
d) Skin
e) Tendon
The correct answer is option D.
Rationale:
In vascularized composite allotransplantation, different tissues elicit varying degrees of immune response. An established, consistent hierarchy of relative antigenicity places skin as the most immunogenic component. This is attributed to its high content of antigen-presenting cells (Langerhans cells), its role as a barrier organ, and the ischemia-reperfusion injury inherent in graft transplantation. The aggressive rejection directed at skin often dictates the intensity of the required immunosuppression protocol. In contrast, bone (option A) and skeletal muscle (option B) are of intermediate to lower immunogenicity, while cartilage (option C) and tendon (option E) are considered among the least antigenic tissues transplanted.
References:
1. Lee WP, Yaremchuk MJ, Pan YC, Randolph MA, Tan CM, Weiland AJ. Relative antigenicity of components of a vascularized limb allograft. Plast Reconstr Surg. 1991.
2. Klimczak A, Siemionow M. Immune responses in transplantation: application to composite tissue allograft. Semin Plast Surg. 2007.
3. Issa F. Vascularized composite allograft-specific characteristics of immune responses. Transpl Int. 2016.
Question:
A 52-year-old woman with a history of stage IIB, hormone receptor-positive, HER2-negative breast cancer completed her final cycle of adjuvant dose-dense doxorubicin, cyclophosphamide, and paclitaxel chemotherapy 12 days ago. She presents to your clinic for consultation regarding elective symmetry procedures on the contralateral breast. She reports feeling well and has no active symptoms. Her most recent complete blood count (CBC), drawn yesterday, shows: white blood cell count 1.2 K/µL, absolute neutrophil count 400/mm³, hemoglobin 10.8 g/dL, and platelets 110 K/µL. Given her current clinical and laboratory status, what is the most appropriate next step in her perioperative management?
a) Proceed with surgery as scheduled; the myelosuppressive effects of chemotherapy are complete.
b) Postpone surgery for at least 2-3 weeks and recheck CBC prior to scheduling.
c) Administer prophylactic broad-spectrum intravenous antibiotics and proceed with surgery.
d) Schedule surgery immediately to avoid potential delays from future chemotherapy cycles.
e) Proceed with surgery but plan for an extended hospital admission for postoperative monitoring.
The correct answer is option B.
Rationale:
The patient is at the typical nadir (lowest point) of chemotherapy-induced myelosuppression, which occurs 10 to 14 days after treatment with regimens containing anthracyclines and cyclophosphamide. Her lab values demonstrate severe neutropenia (absolute neutrophil count <500/mm³), which carries a significant risk for life-threatening infection. Performing elective surgery during this period is contraindicated due to the high risk of neutropenic fever and poor wound healing. The appropriate action is to postpone surgery until bone marrow recovery occurs, which typically takes an additional 2-3 weeks, and to confirm hematologic recovery with a repeat CBC before proceeding.
Proceeding with surgery (option A or D) ignores a critical, time-limited risk. Prophylactic antibiotics (option C) do not adequately mitigate the risk of infection in a severely neutropenic host with impaired immune defenses. An extended admission (option E) does not address the root cause of the risk and is not a substitute for proper timing.
References:
1. Shapiro CL, Recht A. Side effects of adjuvant treatment of breast cancer. N Engl J Med. 2001.
2. Zimmer AJ, Freifeld AG. Optimal management of neutropenic fever in patients with cancer. J Oncol Pract. 2019.
3. Burstein HJ. Systemic therapy for estrogen receptor-positive, HER2-negative breast cancer. N Engl J Med. 2020.
Question:
A 52-year-old woman is scheduled for an immediate unilateral deep inferior epigastric perforator (DIEP) flap breast reconstruction following mastectomy, with surgery set for 7:30 AM. She follows an Enhanced Recovery After Surgery (ERAS) protocol. At 10:00 PM the night before surgery, she eats a light dinner. At 5:30 AM on the day of surgery, she feels thirsty and anxious. Which of the following represents the most appropriate management according to ERAS Society guidelines?
a) Instruct her that she cannot have anything by mouth, as she has already exceeded the traditional “NPO after midnight” requirement.
b) Allow her to drink 200 mL of a clear maltodextrin-based carbohydrate beverage.
c) Allow her to drink 200 mL of whole milk.
d) Allow her to eat a small serving of yogurt.
e) Administer intravenous fluids to address thirst and anxiety.
The correct answer is option B.
Rationale:
Enhanced Recovery After Surgery (ERAS) protocols are evidence-based and have revised traditional perioperative fasting guidelines. ERAS recommends fasting from solid foods for 6 hours but permits clear liquids up to 2 hours before the induction of anesthesia. Furthermore, preoperative carbohydrate loading with clear maltodextrin-based drinks during this window is specifically recommended. It has been shown to improve patient metabolic state, reduce insulin resistance, and decrease preoperative thirst and anxiety without increasing the risk of aspiration.
Option A adheres to an outdated, restrictive “NPO after midnight” rule not supported by current evidence. Options C and D involve milk and yogurt, which are not clear liquids and would require a 6-hour fast, making them inappropriate less than 2 hours before surgery. Option E is incorrect, as the patient can safely drink; IV fluids are not indicated to address simple thirst in this setting and do not provide the metabolic benefits of carbohydrate loading.
References:
1. Ljungqvist O, Scott M, Fearon KC. Enhanced recovery after surgery: a review. JAMA Surg. 2017.
2. Temple-Oberle C, Shea-Budgell MA, Tan M, et al. Consensus review of optimal perioperative care in breast reconstruction: Enhanced Recovery After Surgery (ERAS) Society recommendations. Plast Reconstr Surg. 2017.
Question:
A 68-year-old man with a history of atrial fibrillation and coronary artery disease s/p drug-eluting stent placement 6 months ago presents for evaluation of a symptomatic 3 cm facial basal cell carcinoma requiring surgical excision. His current medications include apixaban 5 mg twice daily for stroke prevention and clopidogrel 75 mg daily for stent patency. He takes aspirin 81 mg daily for primary cardiovascular prevention. Regarding the mechanism of action of his medications, which one of the following works primarily by irreversibly inhibiting cyclooxygenase (COX) enzymes to prevent thromboxane A2 production?
a) Apixaban
b) Clopidogrel
c) Aspirin
d) Warfarin
e) Enoxaparin
The correct answer is option C.
Rationale:
This question tests precise knowledge of antithrombotic drug mechanisms. Aspirin exerts its antiplatelet effect through irreversible acetylation of cyclooxygenase-1 (COX-1) and COX-2 enzymes. This inhibition blocks the synthesis of thromboxane A2, a potent promoter of platelet aggregation and vasoconstriction. In contrast, apixaban (option A) is a direct factor Xa inhibitor, clopidogrel (option B) is a thienopyridine that inhibits the P2Y12 subtype of the ADP receptor on platelets, warfarin (option D) is a vitamin K antagonist, and enoxaparin (option E) is a low molecular weight heparin that enhances antithrombin III activity. Recognizing these distinct pathways is crucial for perioperative management, as it informs both the timing of discontinuation and the understanding of which agents have irreversible effects (like aspirin) versus those with shorter durations of action.
References:
1. Polania Gutierrez JJ, Rocuts KR. Perioperative anticoagulation management. In: StatPearls. StatPearls Publishing; 2024.
2. Douketis JD, Spyropoulos AC. Perioperative management of anticoagulant and antiplatelet therapy. NEJM Evid. 2023.
Question:
A 78-year-old man is evaluated for a complex scalp reconstruction with a free latissimus dorsi flap following wide excision of a recurrent cutaneous malignancy. His past medical history includes diet-controlled type 2 diabetes, hypertension treated with lisinopril, and moderate COPD managed with a daily inhaler. He reports he is fully independent in all activities of daily living and walks one mile daily. His preoperative labs and cardiac clearance are unremarkable. The surgical team is concerned about his risk for postoperative complications and prolonged recovery. Which of the following preoperative assessments is most strongly validated to predict his specific risk of major complications, mortality, and non-home discharge in this setting?
a) Assessment using the American Society of Anesthesiologists (ASA) Physical Status Classification System
b) Risk stratification based on chronological age alone
c) Calculation of his Charlson Comorbidity Index (CCI) score
d) Evaluation using the 11-variable modified frailty index (mFI)
e) Determination of body mass index (BMI) and nutritional prealbumin level
The correct answer is option D.
Rationale:
Frailty, defined as a state of decreased physiologic reserve, is a more powerful predictor of adverse surgical outcomes than chronological age or the presence of individual comorbidities alone. The modified frailty index (mFI), specifically derived from and validated against the NSQIP database, operationalizes this concept by assessing 11 deficits (including functional status, diabetes, COPD, hypertension, etc.). It has been strongly correlated with significantly increased risks of major complications, wound complications, readmission, discharge to a skilled facility, and mortality—outcomes highly relevant to major reconstructive surgery. While the ASA classification (option A) and CCI (option C) assess comorbidity burden, they do not specifically measure the integrated decline in physiologic systems that defines frailty. Age alone (option B) is an inadequate proxy, as highlighted by patients like this one who may be chronologically old but functionally robust. Nutritional markers (option E) assess only one domain of risk.
References:
1. Gallo L, Gallo M, Augustine H, et al. Assessing patient frailty in plastic surgery: a systematic review. J Plast Reconstr Aesthet Surg. 2022.
2. Obeid NM, Azuh O, Reddy S, et al. Predictors of critical care-related complications in colectomy patients using the National Surgical Quality Improvement Program: exploring frailty and aggressive laparoscopic approaches. J Trauma Acute Care Surg. 2012.
3. Panayi AC, Orkaby AR, Sakthivel D, et al. Impact of frailty on outcomes in surgical patients: a systematic review and meta-analysis. Am J Surg. 2019.
Question:
A 24-year-old male is brought to the trauma bay following a high-speed motorcycle collision. He was initially unresponsive at the scene but is now moaning to painful stimuli. Upon arrival, the trauma team performs a systematic assessment. His airway is patent, breath sounds are equal bilaterally, and he is placed on supplemental oxygen. Two large-bore IVs are established, and a focused assessment with sonography for trauma (FAST) exam is negative. After cervical spine precautions are maintained, he is fully exposed, log-rolled, and a back examination is performed. Initial radiographs of the chest and pelvis are unremarkable. A head CT reveals a small subdural hematoma without midline shift. As the team prepares for definitive admission and care, the patient becomes more responsive and complains of new, significant pain in his left lower extremity. His vital signs remain stable. According to Advanced Trauma Life Support (ATLS) principles, what is the most appropriate immediate next step in management?
a) Repeat the primary survey (ABCDE) due to the change in neurological status and new pain complaint.
b) Initiate a tertiary trauma survey to identify any potentially missed injuries.
c) Proceed directly to CT angiography of the lower extremity to evaluate for vascular injury.
d) Administer intravenous analgesia and obtain orthopedic consultation for definitive management.
e) Perform a detailed secondary survey, as the initial assessment was likely interrupted by the patient’s altered mental status.
The correct answer is option B.
Rationale:
The ATLS protocol emphasizes a structured, sequential approach to trauma assessment to identify and address the greatest threats to life first. This case describes a patient who has completed the primary survey (addressing immediate life-threats) and an initial secondary survey (a head-to-toe physical assessment and initial imaging). The development of a new symptom (localized pain) after these initial assessments, once the patient is more alert and stable, is a classic scenario warranting a tertiary survey. The tertiary survey is defined as a systematic, repeated head-to-toe examination performed within 24 hours of admission, specifically designed to identify injuries missed during the initial chaotic evaluation. It is a critical component of definitive care and has been shown to significantly reduce the rate of delayed diagnosis.
Repeating the primary survey (option A) is not indicated as there is no compromise to airway, breathing, or circulation. While further imaging or consultation (options C & D) may be eventual outcomes, the appropriate ATLS-directed step is first to conduct a comprehensive re-evaluation via the tertiary survey to guide subsequent testing. Performing another secondary survey (option E) is incorrect, as one has already been completed; the tertiary survey is the distinct, next-phase evaluation.
References:
1. American College of Surgeons Committee on Trauma. Advanced Trauma Life Support (ATLS) Student Course Manual. 10th ed. American College of Surgeons; 2018.
2. Enderson BL, Reath DB, Meadors J, Dallas W, DeBoo JM, Maull KI. The tertiary trauma survey: a prospective study of missed injury. J Trauma. 1990.
3. Moffat B, Vogt KN, Inaba K, et al. Introduction of a mobile device based tertiary survey application reduces missed injuries: a multi-center prospective study. Injury. 2019.
Question
A 58-year-old patient is undergoing adjuvant radiation therapy following lumpectomy for left breast cancer. Three weeks into treatment, she presents with a well-demarcated area of moderate to brisk erythema on the left chest wall, with patchy areas of moist desquamation confined to the inframammary fold. The area is tender but shows no signs of systemic infection. Which of the following is the most appropriate initial topical management for this presentation?
a) Application of a hydrophilic moisturizing hydrogel
b) Treatment with saline-soaked gauze dressings with plans for operative debridement
c) Use of an antimicrobial hydrocolloid dressing
d) Low-dose topical corticosteroid cream
e) Referral for fractional carbon dioxide laser resurfacing
The correct answer is option C.
Rationale
The clinical description—moderate to brisk erythema with patchy moist desquamation confined to skin folds—is characteristic of a Grade 2 acute radiation dermatitis according to the National Cancer Institute classification. The rationale specifies that treatment for Grade 2 (and Grade 3) injuries focuses on preventing secondary infection and involves the use of antimicrobial hydrocolloid dressings.
References
1. Friedstat J, Brown DA, Levi B. Chemical, electrical, and radiation injuries. Clin Plast Surg. 2017.
2. Bray FN, Simmons BJ, Wolfson AH, Nouri K. Acute and chronic cutaneous reactions to ionizing radiation therapy. Dermatol Ther (Heidelb). 2016.
Question
A 32-year-old woman with confirmed Type 1 von Willebrand disease is scheduled for an elective bilateral carpal tunnel release, classified as a minor surgical procedure. Her baseline von Willebrand factor activity is 35 IU/dL. According to current evidence-based guidelines for perioperative hemostatic management, which of the following regimens is most appropriate for this patient?
a) Administration of intravenous desmopressin 30 minutes preoperatively
b) Administration of intravenous desmopressin combined with intravenous tranexamic acid preoperatively
c) Infusion of von Willebrand factor concentrate to raise activity levels above 50 IU/dL, without additional antifibrinolytic therapy
d) Preoperative administration of tranexamic acid alone
e) No preoperative hemostatic medication is required for this minor procedure
The correct answer is option B.
For patients with von Willebrand disease (vWD) undergoing minor surgery, the evidence-based goal is dual therapy: raise von Willebrand factor (vWF) activity to ≥50 IU/dL AND administer the antifibrinolytic tranexamic acid (TXA).
This patient has Type 1 vWD, the most common and typically responsive form. For a Type 1 patient undergoing a minor procedure, desmopressin (DDAVP) is the first-line agent to raise vWF levels, as it safely releases endogenous stores. Therefore, the most appropriate regimen is DDAVP to achieve the target level + TXA.
Why the other options are incorrect:
A (DDAVP alone) and C (vWF concentrate alone): These provide only half of the required dual-therapy approach. They correct the factor deficiency but fail to inhibit the increased fibrinolysis also present in vWD.
D (TXA alone): This does not correct the underlying factor deficiency (her level of 35 IU/dL is below the 50 IU/dL target).
E (no therapy): Ignores the established bleeding risk in vWD.
Why not vWF Concentrate + TXA? While factor replacement combined with TXA is a valid and effective hemostatic strategy, it is not the first-line choice for a Type 1 patient. vWF concentrate is typically reserved for Type 3 patients, Type 1/2 patients known to be unresponsive to DDAVP, or for major surgery. Using it here would be unnecessarily expensive and less specific than using the patient’s own endogenous factors via DDAVP.
References
Connell NT, Flood VH, Brignardello-Petersen R, et al. ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease. Blood Adv. 2021.
Eghbali A, et al. Efficacy of tranexamic acid for the prevention of bleeding in patients with von Willebrand disease… Haemophilia. 2016.
Question
A 42-year-old patient is scheduled for a bilateral reduction mammaplasty. The surgeon anticipates using monopolar electrocautery at a high setting for an extended duration to achieve hemostasis. To minimize the patient’s risk of an electrosurgical burn at the grounding pad site, which of the following configurations represents the most appropriate placement of two identical grounding pads?
a) One pad on the left upper thigh and the other on the right lower thigh
b) Both pads placed side-by-side on the patient’s left lateral thigh
c) One pad on the left upper arm and the other on the left lower thigh
d) One pad on the right anterior thigh and the other on the right posterior thigh
e) One pad on the left anterior thigh and the other on the right anterior thigh
The correct answer is option E.
Rationale
For high-current procedures like reduction mammaplasty, using two identical grounding pads is recommended to disperse electrical current and minimize the risk of thermal injury. The key safety principle is to divide the current flow equally between the pads. This is achieved by placing the pads symmetrically and equidistant from the surgical site. Placing one pad on the left anterior thigh and the other on the right anterior thigh satisfies this requirement, creating two parallel, low-resistance paths that safely return current to the generator.
References
1. ECRI. Higher currents, greater risks: preventing patient burns at the return-electrode site during high-current electrosurgical procedures. Health Devices. 2005.
2. 3M Health Care. Reducing Grounding Pad Burns During High Current Electrosurgical Procedures. Technical Bulletin; 2007.
3. Vilos G, Latendresse K, Gan BS. Electrophysical properties of electrosurgery and capacitive induced current. Am J Surg. 2001.
Question
A 68-year-old patient presents to your clinic with stage IV (cT4aN2bM1) squamous cell carcinoma of the lateral tongue, with biopsy-proven pulmonary metastases. His oncologist has indicated that the disease is incurable, with an expected median survival of approximately 10 months. The patient has significant trismus and pain from a large, fungating primary tumor. He wishes to explore palliative surgical resection to improve his ability to eat and reduce pain. To best determine whether he is a candidate for and would benefit from a major reconstructive procedure, which of the following tools is the most appropriate to formally assess his current functional status and prognosis?
a) The American Society of Anesthesiologists (ASA) Physical Status Classification System
b) The TNM Classification of Malignant Tumors (8th Edition)
c) The Palliative Performance Scale (PPS)
d) The 5-Item World Health Organization (WHO) Well-Being Index
e) The Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q)
The correct answer is option C.
Rationale
For patients with incurable head and neck cancer being considered for palliative reconstructive surgery, functional status is the critical determinant of who may benefit. The Palliative Performance Scale (PPS) is the specific tool cited in the literature as useful for prognostic stratification in this population. It directly assesses the functional domains relevant to surgical recovery and quality of life—ambulation, activity and evidence of disease, self-care, oral intake, and level of consciousness—providing a percentage score that correlates with survival and functional trajectory. This makes it ideal for identifying “high functioning” patients who might withstand and benefit from palliative surgery. The ASA Classification (a) assesses global preoperative anesthetic risk but does not quantify palliative function or prognosis. The TNM staging (b) describes the anatomic extent of cancer but is not a functional assessment and does not guide palliative surgical suitability. Both the WHO Well-Being Index (d) and the Q-LES-Q (e) are validated psychological well-being questionnaires but do not assess the physical and functional parameters (e.g., ambulation, need for assistance) essential for surgical decision-making in this context.
References
1. Rankin T, Mailey B, Suliman A, Dobke M. Palliative reconstructive surgery may improve quality of life in high functioning noncurable head and neck oncologic patients. Ann Plast Surg. 2015.
2. Miglani A, Patel VM, Stern CS, et al. Palliative reconstruction for the management of incurable head and neck cancer. J Reconstr Microsurg. 2016.
Question
A 42-year-old woman undergoes a routine screening mammogram. She has no personal or family history of breast cancer. The mammogram reveals a new, 8-mm, circumscribed, oval mass in the upper outer quadrant of the right breast. An ultrasound is performed for further characterization, confirming a solid, parallel, oval mass with circumscribed margins. No suspicious features are identified. The radiologist assigns a final assessment category of BI-RADS 3. According to the BI-RADS atlas, what is the associated risk of malignancy for this finding, and what is the most appropriate next step in management?
a) < 2% risk of malignancy; recommend short-interval follow-up imaging in 6 months.
b) 2-9% risk of malignancy; recommend diagnostic biopsy.
c) 10-49% risk of malignancy; recommend immediate diagnostic biopsy.
d) > 95% risk of malignancy; recommend tissue diagnosis and surgical consultation.
e) 0% risk of malignancy; return to routine annual screening.
The correct answer is option A.
Rationale
The BI-RADS (Breast Imaging-Reporting and Data System) lexicon standardizes risk assessment. A BI-RADS category 3 finding is defined as “probably benign,” with an associated risk of malignancy of less than 2%. The standard management for a probably benign lesion is short-interval follow-up imaging, typically in 6 months, to confirm stability.
The other options correspond to incorrect categories and management pathways:
* Option B (2-9% risk) describes a BI-RADS 4A (low suspicion) finding, which warrants biopsy.
* Option C (10-49% risk) describes a BI-RADS 4B (moderate suspicion) finding, which warrants biopsy.
* Option D (>95% risk) describes a BI-RADS 5 (highly suggestive of malignancy) finding, which warrants tissue diagnosis.
* Option E (0% risk) describes a definitively benign BI-RADS 2 finding, which would return to routine screening.
References
1. D’Orsi CJ, Sickles EA, Mendelson EB, et al. ACR BI-RADS® Atlas, Breast Imaging Reporting and Data System. American College of Radiology; 2013.
2. Magny SJ, Shikhman R, Keppke AL. Breast imaging reporting and data system. In: StatPearls. StatPearls Publishing; 2023.
Question
A 48-year-old patient presents to your clinic with a severe, progressive collapse of the nasal dorsum, resulting in a classic saddle-nose deformity. During the history, you learn the patient has a known systemic diagnosis of granulomatosis with polyangiitis (GPA), previously called Wegener’s granulomatosis. This presentation is a recognized manifestation of the disease. Based on the underlying pathology, which of the following best characterizes the disease process responsible for this destructive nasal deformity?
a) A chronic autoimmune disorder characterized by immune complex deposition and inflammatory reactions, often with skin and joint involvement.
b) A systemic condition defined by noncaseating granulomas that can affect multiple organs, including the lungs.
c) A necrotizing granulomatous vasculitis affecting small- to medium-sized blood vessels.
d) A large-vessel vasculitis that predominantly affects the extracranial branches of the carotid artery.
e) An autoimmune exocrinopathy primarily affecting salivary and lacrimal glands.
The correct answer is option C.
Rationale
Granulomatosis with polyangiitis (GPA), formerly known as Wegener’s granulomatosis, is a necrotizing granulomatous vasculitis that affects small- to medium-sized vessels. The destructive saddle-nose deformity occurs due to this vasculitic and granulomatous inflammation targeting the cartilaginous and bony structures of the nose. This directly matches the description in the rationale. The other options describe different diseases: Systemic lupus erythematosus (a) involves immune complex deposition. Sarcoidosis (b) is characterized by noncaseating granulomas. Giant cell (temporal) arteritis (d) is a large-vessel vasculitis. Sjögren syndrome (e) is an autoimmune exocrinopathy. While eosinophilic granulomatosis with polyangiitis (EGPA/Churg-Strauss) is also a vasculitis and can cause similar findings, the rationale specifically and correctly names “Wegener’s granulomatosis” (now GPA) as the frequent cause of saddle-nose deformity.
References
1. Coordes A, et al. Saddle nose deformity and septal perforation in granulomatosis with polyangiitis. Clin Otolaryngol. 2018.
2. Daniel RK, Brenner KA. Saddle nose deformity: a new classification and treatment. Facial Plast Surg Clin North Am. 2006.
3. Alanazi F, et al. Rhinoplasty for sinonasal deformities in granulomatosis with polyangiitis: a systematic review and meta-analysis. J Craniofac Surg. 2023.
Question
A 45-year-old woman presents for an initial consultation regarding a possible facelift. She is highly anxious, providing a meticulously detailed, typed list of over 15 minor asymmetries and “flaws” she wishes corrected. She becomes tearful and angry, stating her current appearance has ruined her life and that she has consulted four other surgeons in the past year who all refused to operate. When gently challenged about the perceived severity of her concerns, she insists that only a perfect surgical outcome will solve her problems. Based on her presentation, which of the following is the most likely and significant psychiatric diagnosis to consider in this patient?
a) Obsessive-compulsive personality disorder
b) Generalized anxiety disorder
c) Body dysmorphic disorder
d) Major depressive disorder
e) Histrionic personality disorder
The correct answer is option C.
Rationale
This vignette portrays a classic presentation of body dysmorphic disorder (BDD), which is the most common psychiatric illness encountered among patients seeking cosmetic surgery. Key diagnostic features include a preoccupation with one or more perceived defects in appearance that are not observable or appear only slight to others; repetitive behaviors (e.g., excessive mirror checking, seeking reassurance, comparing with others) in response to the concerns; and significant distress or impairment in social, occupational, or other areas of functioning—as evidenced by her belief her life is “ruined” and her history of multiple consultations. The prevalence of BDD in cosmetic surgery populations is significantly higher than in the general public. While obsessive-compulsive (a) and histrionic (e) personality disorders are also more common in this population, they do not typically manifest with the core feature of a fixed, distressing preoccupation with a specific imagined physical flaw. Generalized anxiety (b) and major depression (d) may be comorbid but are not the primary, defining pathology in this clinical scenario.
References
1. Bascarane S, Kuppili PP, Menon V. Psychiatric assessment and management of clients undergoing cosmetic surgery: overview and need for an integrated approach. Indian J Plast Surg. 2021.
2. Golshani S, et al. Personality and psychological aspects of cosmetic surgery. Aesthetic Plast Surg. 2016.
3. Herruer JM, et al. Negative predictors for satisfaction in patients seeking facial cosmetic surgery: a systematic review. Plast Reconstr Surg. 2015.
Question
A 55-year-old woman with no known BRCA1/2 mutation was diagnosed with estrogen receptor-positive, early-stage invasive ductal carcinoma of the left breast two years ago. She completed adjuvant chemotherapy and is currently taking endocrine therapy. She is now considering contralateral risk-reducing mastectomy and asks about her actual risk of developing a new primary cancer in the right breast over the next 5 years. According to recent large-scale, population-based studies, which of the following best approximates her current cumulative 5-year risk?
a) <1%
b) 1–2%
c) 4–6%
d) 8–10%
e) 12–15%
A 39-year-old woman presents for a reduction mammaplasty consultation. Physical examination reveals a firm, mobile, 1.5-cm mass in the left breast. Mammography indicates a less than 2% risk of malignancy. Which of the following Breast Imaging Reporting and Data System (BI-RADS) categories best describes these findings?
A) 1
B) 2
C) 3
D) 4
E) 5
The correct response is Option C.
Rationale
The Breast Imaging Reporting and Data System (BI-RADS) standardizes mammography reports and classifies findings into specific categories based on the level of suspicion for malignancy. A BI-RADS 3 assessment is defined as “probably benign,” with a less than 2% risk of malignancy. This classification is appropriate for findings that are very likely benign but still merit short-term follow-up imaging for confirmation. The patient’s mammographic result directly corresponds to this category.
The other options are incorrect:
· A) BI-RADS 1: Indicates a normal study with no abnormalities.
· B) BI-RADS 2: Indicates a clearly benign finding, such as a simple cyst or stable fibroadenoma.
· D) BI-RADS 4: Indicates a suspicious abnormality, with a risk of malignancy ranging from 2% to 94%.
· E) BI-RADS 5: Indicates a highly suggestive finding of malignancy, with a risk greater than 95%.
References
A 45-year-old woman with newly diagnosed invasive lobular carcinoma of the right
breast comes to the clinic to discuss immediate breast reconstruction following
bilateral mastectomy. History includes a sulfonamide allergy; otherwise, she has
no medical comorbidities and does not smoke cigarettes. Staged implant-based
breast reconstruction is planned. Which of the following prophylactic antibiotic
regimens is most appropriate for this patient?
A) Intravenous cefazolin for less than 24 hours perioperatively followed by no oral
antibiotic
B) Intravenous clindamycin for less than 24 hours perioperatively, followed by a 5-day
course of oral trimethoprim-sulfamethoxazole
C) Intravenous clindamycin for less than 24 hours perioperatively, followed by no oral
antibiotic
D) Intravenous piperacillin/tazobactam for less than 24 hours perioperatively, followed
by a 5-day course of oral ciprofloxacin
E) Intravenous vancomycin for less than 24 hours perioperatively, followed by a 5-day
course of cephalexin
The correct response is Option A.
Postoperative surgical site infection (SSI) following implant-based breast reconstruction is a
major complication that can mandate device removal and thereby result in reconstructive
failure. As such, meticulous technique, maintenance of a sterile surgical field, and
perioperative antibiotic prophylaxis are of utmost importance in decreasing postoperative
infection rates.
Historically, antibiotics were used quite liberally following implant-based breast
reconstruction with prophylaxis implemented for an extended duration, frequently until drain
removal. More recent studies, however, have demonstrated that extended postoperative
systemic antibiotics have no significant effect on decreasing the incidence of SSI.
Importantly, Phillips et al demonstrated that antibiotic prophylaxis for an extended duration,
versus less than 24 hours, was associated with a greater rate of expander loss. Therefore,
contemporary recommendations call for antibiotic prophylaxis limited to the perioperative
period only, for less than 24 hours. As to antibiotic choice, the use of beta-lactam antibiotics (eg, cefazolin) was recently
demonstrated as superior to alternative antibiotics with a bacteriostatic mechanism of action
(eg, vancomycin, clindamycin) in regards to rates of postoperative infection and
reconstructive failure following immediate implant-based breast reconstruction.
Trimethoprim-sulfamethoxazole would be contraindicated in this patient given her
sulfonamide allergy. Since perioperative antibiotic prophylaxis is predominantly targeted
against gram-positive bacteria (skin flora), intravenous piperacillin/tazobactam would not be
an appropriate choice.
REFERENCES:
1. Hai Y, Chong W, Lazar M. Extended prophylactic antibiotics for mastectomy with
immediate breast reconstruction: A meta-analysis. Plast Reconstr Surg Glob Open.
2020;8(1):e2613. doi: 10.1097/GOX.0000000000002613
2. Miller TJ, Remington AC, Nguyen DH, Gurtner GC, Momeni A. Preoperative β-lactam
antibiotic prophylaxis is superior to bacteriostatic alternatives in immediate expander-
based breast reconstruction. J Surg Oncol. 2021;124(5):722-730. doi: 10.1002/jso.26599
A 30-year-old woman is scheduled to undergo liposuction of the abdomen, anterior and posterior flanks,
and inner and outer thighs, with an estimated lipoaspirate volume of 5.5 liters. The plastic surgeon has an
in-office operating room that is accredited by the American Association for Accreditation of Ambulatory
Surgery Facilities (AAAASF) and has certified registered nurse anesthetists (CRNAs) performing general
anesthesia. In order to meet AAAASF requirements for a Class C facility, this case must adhere to which
of the following guidelines?
A) General anesthesia must be administered by an anesthesiologist
B) Intravenous sedation must be administered by an anesthesiologist
C) Pathology services must be available to manage all tissues removed from patients
D) Patient must be monitored overnight at the facility if more than 5 L of lipoaspirate are removed
E) The in-office operating room must have a state certificate of needed
The correct response is Option D.
The American Association for Accreditation of Ambulatory Surgery Facilities (AAAASF) is an accrediting
body that certifies that an accredited facility meets nationally recognized standards for safety. The facility
is surveyed every 3 years. There are different classes of facilities.
According to their Basic Mandates:
In a Class A facility, procedures “may be performed under topical or local anesthesia only; only minimal
sedation levels are permitted, and no more than 500 cc’s of aspirate can be removed via liposuction.”
In a Class B facility, “parenteral sedation, field and peripheral nerve blocks and dissociative drugs
(excluding propofol) may be administered by a/an physician, certified registered nurse anesthetist
(CRNA) with physician supervision, anesthesia assistant under direct supervision of an anesthesiologist
or registered nurse (RN) under qualified physician supervision. The use of propofol, spinal and epidural
anesthesia, endotracheal intubation, laryngeal mask airway, and/or inhalation general anesthesia is
prohibited. No more than 5L of aspirate can be removed via liposuction unless the patient is monitored
overnight in the facility.”
In a Class C facility, “all types of anesthesia listed above can be administered including general
anesthesia (with or without endotracheal intubation or laryngeal mask airway), and propofol can be
administered by a/an physician, CRNA with physician supervision, anesthesia assistant under direct
supervision of an anesthesiologist or RN under qualified physician supervision. No more than 5L of
aspirate can be removed via liposuction unless the patient is monitored overnight in the facility.”
Certificate of need relates to insurance cases and is not a mandate of the AAAASF. There is no mandate
requiring pathologic examination availbility.
American Association for Accreditation of Ambulatory Surgery Facilities, Inc. Regular standards and
checklist for accreditation of ambulatory surgery facilities: version 14.5. https://www.aaaasf.org/wpcontent/
uploads/2019/09/Standards-and-Checklist-Manual-V-14.5.pdf. Revised March 2017. Accessed
December 30, 2019.
2. Pearcy J, Terranova T. Mandate for accreditation in plastic surgery ambulatory/outpatient clinics. Clin
Plast Surg. 2013;40(3):489-492.
A 56-year-old man is brought to the emergency department after sustaining an
isolated Gustilo Type IIIB fracture when he fell from a roof. He undergoes
definitive orthopedic fixation and is left with a 10 × 15-cm wound in the distal third
of the leg with exposed hardware. Free tissue transfer is successfully performed
for wound closure at the time of fracture fixation. One week after closure, the
patient is classified as weight-bearing as tolerated and is ready to be discharged
from the hospital. Which of the following is the most appropriate prophylaxis for
venous thromboembolism on discharge of this patient?
A) Aspirin 325 mg daily for 2 weeks
B) Aspirin 325 mg daily for 4 weeks
C) Low-molecular-weight heparin 40 mg daily for 2 weeks
D) Low-molecular-weight heparin 40 mg daily for 4 weeks
E) No prophylaxis is indicated
The correct response is Option D.
Venous thromboembolism (VTE) is a major complication following orthopedic injury. For
patients who undergo major orthopedic surgery, it is suggested that dual prophylaxis with
compression devices and antithrombotic agents be used while hospitalized. It is also
suggested to extend venous thromboembolism prophylaxis, in the form of low-molecular-
weight heparin, to a period of up to 35 days from the day of surgery rather than for only 10 to
14 days.
Aspirin is more commonly used in total joint arthroplasty and currently not recommended as
VTE prophylaxis in orthopedic trauma patients.
REFERENCES:
1. Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery
patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American
College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest.
2012;141(2):e278s-e325s. doi: 10.1378/chest.11-2404
2. Kahn SR, Shivakumar S. What’s new in VTE risk and prevention in orthopedic surgery.
Res Pract Thromb Haemost. 2020;4(3):366-376. doi:10.1002/rth2.12323
A 26-year-old woman with a strong family history of breast cancer undergoes genetic testing. She is found to have a deleterious mutation of the BRCA1 gene. Which of the following best describes her lifetime risk for the development of breast cancer when compared with women without this mutation?
A) Two times greater
B) Six times greater
C) Ten times greater
D) Fifteen times greater
E) Twenty times greater
Correct answer is option B.
A woman’s lifetime risk of developing breast and/or ovarian cancer is greatly increased if she inherits an altered BRCA1 or BRCA2 gene. Women with an inherited alteration in one of these genes have an increased risk of developing these cancers at a young age (before menopause) and often have multiple close family members with the disease. These women may also have an increased chance of developing colon cancer.
Men with an altered BRCA1 or BRCA2 gene also have an increased risk of breast cancer (primarily if the alteration is in BRCA2) and possibly prostate cancer. Alterations in the BRCA2 gene have also been associated with an increased risk of lymphoma, melanoma, and cancers of the pancreas, gallbladder, bile duct, and stomach in some men and women.
According to estimates of lifetime risk, approximately 13.2% (132 of 1000 individuals) of women in the general population will develop breast cancer, compared with estimates of 36 to 85% (360 to 850 of 1000) of women with an altered BRCA1 or BRCA2 gene. In other words, women with an altered BRCA1 or BRCA2 gene are 3 to 7 times more likely to develop breast cancer than women without alterations in those genes. Lifetime risk estimates of ovarian cancer for women in the general population indicate that 1.7% (17 of 1000) will get ovarian cancer, compared with 16 to 60% (160 to 600 of 1000) of women with altered BRCA1 or BRCA2 genes. No data are available from long-term studies of the general population comparing the cancer risk in women who have a BRCA1 or BRCA2 alteration with women who do not have an alteration in these genes. Therefore, these figures are estimated ranges that may change as more research data are added.
An otherwise healthy 52-year-old woman comes to the office forconsultation for bilateral mastopexy. Her
last mammogram 2 years ago was negative. Physicalexamination shows a palpable breast mass in the
upper outer quadrant of the right breast that the patient has not noticed previously. Which of the following
is the most appropriate next step in management?
A) Core needle biopsy
B) Diagnostic mammogram with ultrasound
C) Fine-needle aspiration biopsy
D) Mastopexy with open biopsy
E) Screening mammogram
The correct response is Option B.
The first step in the management of a newly found palpable breast mass is x-ray imaging to further
characterize the tumor. The type of imaging required typically depends on the age of the patient at
presentation. In females less than 30 years of age, ultrasound is typically the first (and possibly only) test
ordered as the breast tissue is typically denser and mammography is not as effective. In women greater
than 30 years of age, mammogram is usually the first test ordered. Mammography can evaluate both
breasts for other incidental findings as well as further characterize the mass. Unless the results of the initial mammogram are definitive of a benign etiology of the mass, then an ultrasound is typically
necessary as well. Ultrasound can distinguish cystic from solid masses and will help delineate the
shape, borders, and acoustic properties of the mass. When the mass is suspicious, biopsy is guided by
ultrasonography but this is typically not the initial treatment.
Mammography can be used for both screening and diagnosis. Screening mammography consists of two
routine views, craniocaudal and mediolateral oblique, and is appropriate for asymptomatic
patients. Diagnostic mammography incorporates additional views (e.g. tangential or spot compression
views) in order to better delineate the area of concern. The current patient has a new finding of palpable
mass on exam and requires a diagnostic mammogram for proper evaluation and management.
Given the patient’s age and presentation with newly palpable mass, x-ray imaging prior to any surgery is
warranted to rule out malignancy. Proceeding with surgery that would rearrange the breast tissue may
compromise the oncologic management of a possible breast cancer with incomplete excision and inability
to obtain reliable margins that would require a completion mastectomy instead of the option for breastconserving
therapy.
Reference(s)
1. Brown AL, Phillips J, Slanetz PJ, et al. Clinical Value of Mammography in the Evaluation of Palpable
Breast Lumps in Women 30 Years Old and Older. AJR Am J Roentgenol. 2017 Oct;209(4):935-942.
2. Harvey JA, Mahoney MC, Newell MS, et al. ACR Appropriateness Criteria Palpable Breast Masses. J
Am Coll Radiol. 2013 Oct;10(10):742-9.e1-3.
3. Stein L, Chellman-Jeffers M. The Radiologic Workup of a Palpable Breast Mass. Cleve Clin J Med.
2009; 76(3): 175-180.
A 27-year-old man sustained multiple facial fractures when he was involved in a motorcycle collision. On
arrival to the emergency department, blood pressure is 80/50 mmHg and heart rate is 150 bpm.
Significant retropharyngeal bleeding is noted. Trauma workup reveals no other injuries. CT angiography
shows active bleeding from the right maxillary artery. Angioembolization is planned and massive
transfusion protocol is initiated. Which of the following is the most appropriate intravenous resuscitation in
this patient?
A) Fresh frozen plasma (FFP) and packed red blood cells (pRBC) in a 1:1 ratio; discontinuation of crystalloids
B) FFP and pRBC in a 1:1 ratio; crystalloids via rapid transfuser (max rate)
C) FFP and pRBC in a 1:4 ratio; crystalloids at 125 cc/h
D) FFP and pRBC in a 1:4 ratio; discontinuation of crystalloids
E) FFP and pRBC in a 4:1 ratio; crystalloids via rapid transfuser (max rate)
The correct response is Option A.
For initiation of a massive transfusion protocol, transfusing fresh frozen plasma (FFP) and packed red
blood cells (pRBC) at a 1:1 ratio and discontinuing intravenous crystalloids is the most appropriate next
step in patient management.
Massive Transfusion Protocol guidelines have been set forth by the American College of Surgeons
through its Trauma Quality Improvement Program (TQIP). Recommendations for initiating a massive
transfusion protocol include:
1. Beginning universal blood product infusion rather than crystalloid or colloid solutions,
2. Transfusing universal pRBC and FFP in a ratio between 1:1 and 1:2 (FFP:pRBC),
3. Transfusing one single donor apheresis or random donor platelet pool for each six units of pRBC.
It is also suggested to deliver pRBC and FFP by a rapid transfuser and through a blood warmer, and that
the initial rate of transfusion should restore perfusion while allowing for “permissive hypotension” until the
operation or angioembolization to stop the bleeding begins.
A 26-year-old man is scheduled to undergo septorhinoplasty following a nasal bone fracture 3 years ago.
He has mild von Willebrand disease. The day of the operation, the surgeon administers 0.3 g/kg of 1-
deamino-8-D-arginine-vasopressin before and after the surgery to help decrease postoperative bleeding.
Which of the following is the initial mechanism by which the administered medication facilitates
hemostasis in this patient?
A) Activating the Factor V Leiden molecule in the clotting cascade
B) Cleaving the fibrinogen molecule to fibrin
C) Inducing the release of von Willebrand factor from its storage sites in endothelial cells
D) Irreversibly blocks the formation of thromboxane A2 in platelets
E) Supporting complex formation with tissue factor, thereby providing enough thrombin to form fibrin plugs to stop
minor bleeds
The correct response is Option C.
This patient is suffering from a bleeding disorder called von Willebrand disease (VWD), which occurs
when the von Willebrand factor (VWF) is deficient or qualitatively abnormal.
Von Willebrand factor (VWF) works by mediating the adherence of platelets to one another and to sites of
vascular damage. It also binds to Factor VIII, keeping it inactive while in circulation since Factor VIII
rapidly degrades when not bound to VWF.
VWD is the most common of the inherited bleeding disorders, with an estimated prevalence in the
general population of 1 percent by laboratory testing. Patients will often present with signs of easy
bruising, extensive bleeding after dental work, heavy or long menstrual periods, and prolonged nose
bleeds. Patients with a history of abnormal bleeding should always be properly worked up prior to
surgery. There has been an extensive discussion over the years about the treatment of patients suffering
from von Willebrand’s disease and rhinoplasty procedure.
The recommended treatment of patients suffering from VWD undergoing rhinoplasty procedure is 0.3
μg/kg of 1-deamino-8-D-arginine-vasopressin (Desmopressin). Desmopressin is an analogue of
vasopressin that exerts a substantial hemostatic effect, by inducing the release of von Willebrand factor
from its storage sites in endothelial cells. Patients with the mild form of VWD have lower than normal
levels of VWF, and the release of the additional proteins from the endothelial cells aids with clotting.
Factor V Leiden is a mutated form of human Factor V, which condition that result in a hypercoagulable
state. Due to this mutation, Protein C, an anticoagulant protein which normally inhibits the pro-clotting
activity of factor V, is not able to bind normally to Factor V, leading to a hypercoagulable state.
Desmopressin does not have a direct interaction on this molecule.
Thrombin is an enzyme that converts fibrinogen to fibrin, and a reaction that leads to the formation of a
fibrin clot. There are several thrombin products commercially available.
Hemophilia is a condition that is deficient in Factor VII. Recombinant activated factor VII.
Aspirin irreversibly blocks the formation of thromboxane A2 in platelets, producing an inhibitory effect on
platelet aggregation.
Reference(s)
1. Ozgönenel B, Rajpurkar M, Lusher JM. How do you treat bleeding disorders with desmopressin?.
Postgrad Med J. 2007;83(977):159–163.
A 10-year-old boy undergoes surgical repair of microtia of the right ear. During cartilage rib harvest, the
right thorax is damaged with visualization of the lung. After repair of the pleura, Valsalva maneuver is
performed with no evidence of an air leak. An intraoperative chest x-ray is negative for pneumothorax.
Several minutes later in the PACU, the patient becomes hypotensive and tachypneic, and his oxygen
saturation decreases to the mid-80s, despite use of a non-rebreather mask.Which of the following is the
most appropriate next step in management?
A) Draw arterial blood gas
B) Intubation
C) Needle decompression of the right chest
D) Open the chest incision
E) Portable chest x-ray study
The correct response is Option C.
The patient shows all the signs of tension pneumothorax, and although the precise etiology is unclear,
the patient requires decompression.
Intubation will not help relieve the tension and pressure, with decreased venous return jeopardizing
hemodynamic stability.
Immediate chest x-ray is inappropriate because of the time required.
Opening the chest incision is not a good option because it requires surgical equipment, general
anesthesia, and cannot be completed in a timely fashion.
Needle decompression at the second intercostal is the standard of care to decompress a tension
pneumothorax. After oxygen saturation and hemodynamics are stabilized, definitive treatment of
pneumothorax can be pursued. This would include placement of chest tube to low suction and serial
chest x-ray to monitor the progress of the lung inflation.
Arterial blood gas will not help make the diagnosis and potentially will delay the appropriate intervention.
Reference(s)
1. Sahn SA, Heffner JE. Spontaneous pneumothorax. N Engl J Med. 2000; 342:868.
2. Dotson K, Johnson LH. Pediatric spontaneous pneumothorax. Pediatr Emerg Care. 2012; 28:715.
3. Romo T, Baratelli R, Raunig H. Avoiding complications of microtia and otoplasty. Facial Plast Surg.
2012 Jun;28(3):333-9.
A 70-year-old woman is evaluated in the office for delayed breast reconstruction.
The modified 5-Item Frailty Index is used to estimate her perioperative risk. A
history of which of the following is considered in the calculation of this index?
A) Cerebrovascular accident
B) Congestive heart failure
C) Coronary artery disease
D) Peripheral vascular disease
E) Pulmonary hypertension
The correct response is Option B.
While advanced age has been historically considered a risk factor for increased postoperative
complications, this idea has been challenged in the literature, particularly in plastic surgery
where many procedures are elective and patients can be functionally optimized for surgery.
More recently, the concept of frailty has been suggested as an alternative and better predictor for
poor surgical outcomes. While the original Canadian Study of Health and Aging Frailty Index
consisted of 70 items, the modified 5-Item Frailty Index has shown similar predictive value with
increased simplicity. The components of the modified 5-Item Frailty Index include the
following:
• Functional status before surgery
• Diabetes mellitus
• Chronic obstructive pulmonary disease
• Congestive heart failure
• Hypertension requiring medication
REFERENCES:
1. Magno-Pardon DA, Luo J, Carter GC, Agarwal JP, Kwok AC. An analysis of the modified
five-item frailty index for predicting complications following free flap breast reconstruction.
Plast Reconstr Surg. 2022;149(1):41-47. doi:10.1097/PRS.0000000000008634
2. Subramaniam S, Aalberg JJ, Soriano RP, Divino CM. New 5-Factor modified frailty index
using American College of Surgeons NSQIP Data. J Am Coll Surg. 2018;226(2):173-181.e8.
doi:10.1016/j.jamcollsurg.2017.11.005